Women with PCOS are at 47% greater risk of death than their peers without the condition
Finland: A recent study by Finland researchers has revealed an increased risk of premature mortality in women with PCOS (polycystic ovary syndrome).
The study, presented at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill, found that women with PCOS have a 47% increased risk for mortality at younger ages versus those without the condition.
"The findings underscore the need for improving the care of diabetes, cardiovascular diseases, and lung infections to prevent the excess mortality of PCOS omen," said co-author Terhi Piltonen, M.D., PhD., of the University of Oulu and Oulu University Hospital in Oulu, Finland.
In women, PCOS is a common cause of infertility that affects about 7% to 10% of women of reproductive age. People with PCOS may have higher levels of testosterone and other reproductive hormones called androgens, cysts on the ovaries, and irregular periods. The condition increases the risk of developing cardiovascular diseases and diabetes.
The researchers designed a register-based case-controlled study to challenge the e limited data within the literature on the mortality risk among PCOS patients. Women with PCOS were identified in the Finnish Care Register for Health Care using ICD codes.
The study was presented at the Society’s ENDO 2023 reproductive health news conference on Thursday, June 15.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.